Literature DB >> 33912506

The COVID-19 Vaccine Saga: A Perspective.

Shashank M Patil1, Ramith Ramu1.   

Abstract

Entities:  

Year:  2021        PMID： 33912506      PMCID： PMC8067902          DOI： 10.4103/jrpp.JRPP_20_100

Source DB:  PubMed          Journal:  J Res Pharm Pract        ISSN： 2279-042X


× No keyword cloud information.
  4 in total

1.  Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

Authors:  Pedro M Folegatti; Katie J Ewer; Parvinder K Aley; Brian Angus; Stephan Becker; Sandra Belij-Rammerstorfer; Duncan Bellamy; Sagida Bibi; Mustapha Bittaye; Elizabeth A Clutterbuck; Christina Dold; Saul N Faust; Adam Finn; Amy L Flaxman; Bassam Hallis; Paul Heath; Daniel Jenkin; Rajeka Lazarus; Rebecca Makinson; Angela M Minassian; Katrina M Pollock; Maheshi Ramasamy; Hannah Robinson; Matthew Snape; Richard Tarrant; Merryn Voysey; Catherine Green; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal:  Lancet       Date:  2020-07-20       Impact factor: 79.321

Review 2.  Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.

Authors:  Junxiong Pang; Min Xian Wang; Ian Yi Han Ang; Sharon Hui Xuan Tan; Ruth Frances Lewis; Jacinta I-Pei Chen; Ramona A Gutierrez; Sylvia Xiao Wei Gwee; Pearleen Ee Yong Chua; Qian Yang; Xian Yi Ng; Rowena Ks Yap; Hao Yi Tan; Yik Ying Teo; Chorh Chuan Tan; Alex R Cook; Jason Chin-Huat Yap; Li Yang Hsu
Journal:  J Clin Med       Date:  2020-02-26       Impact factor: 4.241

3.  Immunogenicity of a DNA vaccine candidate for COVID-19.

Authors:  Trevor R F Smith; Ami Patel; Stephanie Ramos; Dustin Elwood; Xizhou Zhu; Jian Yan; Ebony N Gary; Susanne N Walker; Katherine Schultheis; Mansi Purwar; Ziyang Xu; Jewell Walters; Pratik Bhojnagarwala; Maria Yang; Neethu Chokkalingam; Patrick Pezzoli; Elizabeth Parzych; Emma L Reuschel; Arthur Doan; Nicholas Tursi; Miguel Vasquez; Jihae Choi; Edgar Tello-Ruiz; Igor Maricic; Mamadou A Bah; Yuanhan Wu; Dinah Amante; Daniel H Park; Yaya Dia; Ali Raza Ali; Faraz I Zaidi; Alison Generotti; Kevin Y Kim; Timothy A Herring; Sophia Reeder; Viviane M Andrade; Karen Buttigieg; Gan Zhao; Jiun-Ming Wu; Dan Li; Linlin Bao; Jiangning Liu; Wei Deng; Chuan Qin; Ami Shah Brown; Makan Khoshnejad; Nianshuang Wang; Jacqueline Chu; Daniel Wrapp; Jason S McLellan; Kar Muthumani; Bin Wang; Miles W Carroll; J Joseph Kim; Jean Boyer; Daniel W Kulp; Laurent M P F Humeau; David B Weiner; Kate E Broderick
Journal:  Nat Commun       Date:  2020-05-20       Impact factor: 14.919

4.  Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.

Authors:  Feng-Cai Zhu; Xu-Hua Guan; Yu-Hua Li; Jian-Ying Huang; Tao Jiang; Li-Hua Hou; Jing-Xin Li; Bei-Fang Yang; Ling Wang; Wen-Juan Wang; Shi-Po Wu; Zhao Wang; Xiao-Hong Wu; Jun-Jie Xu; Zhe Zhang; Si-Yue Jia; Bu-Sen Wang; Yi Hu; Jing-Jing Liu; Jun Zhang; Xiao-Ai Qian; Qiong Li; Hong-Xing Pan; Hu-Dachuan Jiang; Peng Deng; Jin-Bo Gou; Xue-Wen Wang; Xing-Huan Wang; Wei Chen
Journal:  Lancet       Date:  2020-07-20       Impact factor: 202.731
  4 in total
  1 in total

1.  Comparative molecular docking and simulation analysis of molnupiravir and remdesivir with SARS-CoV-2 RNA dependent RNA polymerase (RdRp).

Authors:  Shashank M Patil; K R Maruthi; Shrisha Naik Bajpe; V M Vyshali; S Sushmitha; Chagalamari Akhila; Ramith Ramu
Journal:  Bioinformation       Date:  2021-11-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.